High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients. (Q53247758)
Jump to navigation
Jump to search
scientific article published on 18 October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients. |
scientific article published on 18 October 2013 |
Statements
High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients. (English)
Hao Huang
Yong Han
Jing Gao
Junnan Feng
Lei Zhu
Like Qu
Lin Shen
Chengchao Shou
18 October 2013
30
4
748
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference